Skip to main content

Table 1 Echocardiographic evaluation for each group

From: Echocardiographic integrated backscatter for detecting progression and regression of aortic valve calcifications in rats

  Baseline    Week 9    Week 21   
  Gr 1 (N=14) Gr 2 (N=14) p (Gr 1 vs. Gr 2) Gr 1 (N=14) Gr 2 (N=14) p (Gr 1 vs. Gr 2) Gr 1 (N=8) Gr 2 (N=8) p (Gr 1 vs. Gr 2)
  Adenine 0.5% Controls   Adenine 0.5% Controls   Adenine 0.5% Controls  
EF (%) 83 ± 2 84 ± 1 0.690 67 ± 3 ** 75 ± 1 ** 0.013 78 ± 1 *# 74 ± 3 * 0.328
CO (ml/min) 171 ± 11 163 ± 11 0.616 95 ± 6 ** 185 ± 6 * < 0.001 214 ± 18 # 207 ± 7 0.738
E/A 1.72 ± 0.18 1.61 ± 0.07 0.970 1.53 ± 0.06 1.52 ± 0.05 0.881 1.48 ± 0.09 1.51 ± 0.07 0.787
Dec time (ms) 44 ± 2 43 ± 1 0.707 45 ± 3 42 ± 2 0.522 47 ± 2 42 ± 2 0.103
AV Area (mm2) 5.1 ± 0.2 4.6 ± 0.3 0.217 5.1 ± 0.4 6.0 ± 0.4 * 0.095 9.5 ± 1.2 *# 8.2 ± 0.7 *# 0.505
Aortic Peak PG (mmHg) 1.77 ± 0.13 1.64 ± 0.10 0.329 0.97 ± 0.08 * 1.48 ± 0.17 0.020 1.46 ± 0.16 # 1.67 ± 0.12 0.317
Aortic Mean PG (mmHg) 1.30 ± 0.10 1.17 ± 0.07 0.376 0.68 ± 0.05 * 1.02 ± 0.11 0.008 1.17 ± 0.08 # 1.18 ± 0.09 0.925
  1. Data are represented as means ± SEM. AV, aortic valve; CO, cardiac output; Dec Time, deceleration time; EF, ejection fraction; Gr., group; PG, pressure gradient. * Vs. Baseline; p < 0.05. ** Vs. Baseline; p < 0.001. # Vs. Week 9; p < 0.05.